sublingual delivery glp-1 receptor agonists How Evolved from Diabetes to Weight Loss Treatments GLP-1 Receptor Agonists for Weight

Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective

"People living with obesity deserve solutions and support, including access to FDA-approved options - never shame or blame

3.9% (obesity) Pregnancy loss higher in all groups with metabolic risk (2329%) Live birth rate: 59% (GLP-1 RA group) Conclusion: Reassuring data with no signal for increased congenital malformations

On the other hand, acute subcutaneous (SC) injection of GLP-1 increases HR and BP transiently in healthy human subjects, returning to normal ranges 50-60 min after injection [54]

Potential Side Effects and Long-Term Risks Common side effects include nausea, vomiting, digestive issues, and fatigue

2013 Apr;20(2):87-97